戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oxine (T4; 10(-7) mol/L) or 3,5,3'-triiodo-l-thyronine (10(-9) mol/L).
2 ater than 100 microM included 3',5'-diiodo-L-thyronine (3',5'-l-T2), 3-iodo-L-thyronine (L-T1), 3'-io
3 -l-T2), 3-iodo-L-thyronine (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-thyronine (L-T0).
4 othyronine (reverse T3; r-T3), 3,3'-diiodo-L-thyronine (3,3'-l-T2) and 3,5-diiodo-L-thyronine (3,5-D-
5 diiodo-l-thyronine (3,5-T(2)), 3,3'-diiodo-l-thyronine (3,3'-T(2)), and 3-iodo-l-thyronine (3-T(1)),
6 odo-L-thyronine (3,3'-l-T2) and 3,5-diiodo-L-thyronine (3,5-D-T2).
7 5'-triiodo-l-thyronine (rT(3)), 3,5-diiodo-l-thyronine (3,5-T(2)), 3,3'-diiodo-l-thyronine (3,3'-T(2)
8 diiodo-l-thyronine (3,3'-T(2)), and 3-iodo-l-thyronine (3-T(1)), in the brain and thyroid gland (TG)
9 s of two thyroxine analogs, 3,3',5-triiodo-L-thyronine and 3,3',5-triiodothyroacetic acid, on purifie
10                 Inhibiting 3,5,3'-tri-iodo-L-thyronine and 3,5,3',5'-tetra-iodo-L-thyronine secretion
11 ycholate, 5-leuenkephalin, triiodothyronine, thyronine, dabsyl-L-valine, and N-benzoyl-L-arginyl-4-am
12 (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-thyronine (L-T0).
13 5'-diiodo-L-thyronine (3',5'-l-T2), 3-iodo-L-thyronine (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-t
14 arkedly decreased serum T3 (3,3 ,5-triiodo-l-thyronine), maternal hepatotoxicity, and increased multi
15  the 5'-position (DIBRT, GC-14) of the outer thyronine ring or from the bridging carbon (HY-4).
16 riiodo-l-thyronine (T(3)), 3,3',5'-triiodo-l-thyronine (rT(3)), 3,5-diiodo-l-thyronine (3,5-T(2)), 3,
17 yl derivatives sharing the GC-1 halogen-free thyronine scaffold.(4) One compound (NH-3) is a T(3) ant
18 -iodo-L-thyronine and 3,5,3',5'-tetra-iodo-L-thyronine secretion did not alter isoform switching, sug
19 the effects of MB07811 with 3,5,3'-triiodo-l-thyronine (T(3)) and a non-liver-targeted TR agonist, 3,
20                                   Tri-iodo-l-thyronine (T(3)) suppresses the proliferation of near-te
21 ix THs, l-thyroxine (T(4)), 3,3',5-triiodo-l-thyronine (T(3)), 3,3',5'-triiodo-l-thyronine (rT(3)), 3
22  were performed in control, 10-day triiodo-l-thyronine (T(3))-treated (model of increased UCP3 expres
23 he hormones, estradiol, and 3,3',5-triiodo-l-thyronine (T(3)).
24  (-54%), adiponectin (-49%), 3,5,3'-tri-iodo-thyronine (T3) (-39%), and testosterone (-11%).
25         The thyroid hormone 3,5,3'-triiodo-L-thyronine (T3) and T4 were equipotent stimulators of PCN
26    Thyroid hormones such as 3,3',5 triiodo-L-thyronine (T3) control numerous aspects of mammalian dev
27                             3,5,3'-triiodi-l-thyronine (T3) had a greater effect on increasing HR in
28 t has been shown to undergo 3,3',5-triiodo-L-thyronine (T3) induced conformational changes.
29         The thyroid hormone 3,3',5-triiodo-l-thyronine (T3) is essential for growth, differentiation,
30                                   Tri-iodo-L-thyronine (T3) treatment of cultured cardiomyocytes for
31 xisome proliferators (PPs), 3,3',5-triiodo-L-thyronine (T3), and 9-cis retinoic acid (9-cis RA) induc
32 d the role of the hormone, 3,3', 5-triiodo-L-thyronine (T3), in the nuclear translocation and targeti
33 orted that thyroid hormone, 3,3',5-triiodo-l-thyronine (T3), increased Na,K-ATPase activity of adult
34 nteractions with the ligand 3,3',5 triiodo-l-thyronine (T3), RXR, DNA, and co-activators such as SRC1
35 omparing the repertoires of 3,3',5-triiodo-L-thyronine (T3)-responsive genes of two neural cell lines
36 sed thyroid hormone levels (3,3',5-triiodo-l-thyronine [T3]).
37  hormones (L-thyroxine, T4; 3,5,3'-triiodo-L-thyronine, T3) and is overexpressed in ovarian cancer.
38 igated how thyroid hormone (3,5',5-triiodo-l-thyronine, T3) inhibits binding of thyroid hormone recep
39            Thyroid hormone (3,5,3'-triiodo-L-thyronine, T3) is an endocrine hormone that exerts homeo
40  0.24 mM, whereas thyroid hormone (triiodo-L-thyronine, T3) stabilizes an inactive monomeric form of
41 loro-4,4'-biphenyldiol, and 3,3',5-triiodo-l-thyronine were determined.
42 ind triiodothyronine (T(3), 3,5,3'-triiodo-l-thyronine) with high affinity, and its precursor thyroxi
43 ursor thyroxine (T(4), 3,5,3',5'-tetraiodo-l-thyronine) with lower affinity.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。